α-Synuclein in PD and superoxide dismutase 1 (SOD1) in ALS can activate NLRP3 in microglia, causing caspase-1 activation and IL-1β maturation, ultimately leading to the development and progression of related diseases [95, 96]. This evidence concerns the gene NLRP3 and Parkinson disease.